G
The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection (TTI) Monitoring System (TTIMS) Laboratory and Risk Factor Database Coordinating Center (LRCC).
See Attachments for Solicitation, Statement of Work and related documents